Radiation therapy for lymphoma patients
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy, Injuries & trauma clinical trials.
This trial studies the effects of radiation therapy on the chest area (mediastinum) in patients with lymphoma or thymoma. It aims to see how well modern radiation works after chemotherapy and may help improve treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 15 years when you receive radiation therapy.
- You have been diagnosed with Hodgkin lymphoma, non-Hodgkin lymphoma, or a thymoma that was removed.
- The radiation treatment must be aimed at the chest area (mediastinum).
- You have completed chemotherapy and will start radiation within one month after your final scans.
- You are in generally good health (able to care for yourself) and have a life expectancy of at least 12 months.
- You are not pregnant or breastfeeding, and you have not had radiation to the chest, breast, or head/neck before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests proton therapy, a precise type of radiation, to treat lymphoma in the chest. The goal is to reduce damage to healthy organs while still curing the cancer.
This study collects information about adults with lymphoma who need treatment that targets the chest/mediastinum. It focuses on how proton radiation may help protect the heart, lungs, and breast compared with the more common photon radiation.
This trial tests if giving radiation after surgery can help people with non-small cell lung cancer that has spread to multiple lymph nodes in the chest. It may offer a treatment option for those who have not had chemotherapy or immunotherapy before.
This trial tests whether giving radiation to the internal mammary lymph nodes (the lymph nodes behind your breastbone) can help women with high-risk breast cancer after they have had chemotherapy before surgery. It is for people whose cancer has spread to nearby lymph nodes despite chemotherapy.
This Phase 3 trial tests whether a shorter, more focused radiation treatment to the regional lymph nodes works as well as the current standard approach for certain breast cancers. It may help patients by potentially improving treatment efficiency while keeping cancer control effective.
This trial tests giving radiation therapy before surgery for a type of thymus gland tumor (thymoma) that has grown into nearby tissues but has not been treated yet. The goal is to see if this approach can make the tumor removable and improve outcomes.
Hear when a new Hodgkin Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.